Market Overview:
The global cancer cachexia market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The market growth is attributed to the increasing incidence of cancer, rising geriatric population, and technological advancements in the field of oncology. Based on type, the global cancer cachexia market is segmented into progestogens, corticosteroids, combination therapies, and others. Progestogens are expected to dominate the market during the forecast period owing to their ability to improve appetite and weight gain in patients with cancer cachexia. Corticosteroids are also anticipated to witness significant growth during the forecast period due their anti-inflammatory properties that help reduce inflammation-associated muscle wasting. Based on application, hospital stores accounted for majority share of the global cancer cachexia market in 2017 owingto increased demand for these drugs for treatment of various types of cancers such as pancreatic carcinoma and gastric carcinoma. However, retail pharmacy store is projectedto be fastest growing segment duringthe forecast perioddue its increasing popularity among consumersfor purchaseof drugs overthe counter (OTC).
Product Definition:
Cachexia is a wasting syndrome associated with advanced cancer, AIDS, and other chronic diseases. It is characterized by the loss of muscle mass and body weight, as well as general weakness and fatigue.
Progestogens:
Progestogens are female hormones that act as the body's natural contraceptive. They are also used to treat certain types of cancer and CVS ( cachexia, or weight loss, due to disease or medical condition) conditions. Progestogen is a type of hormone that is produced in the ovary and it does not have any effect on a man.
Corticosteroids:
Corticosteroids are the group of drugs, which acts as anti-inflammatory agents and helps in reducing inflammation. It reduces the immune response to any foreign substance (such as radiation therapy), by inhibiting cytokine production. Corticosteroids can be administered orally, topically or systemically in cancer patients undergoing chemotherapy or radiotherapy for control/amelioration of side effects such as hypertension, gastrointestinal intolerance and allergic reactions along with improving survival rates.
Application Insights:
The cancer chemotherapy application segment dominated the global market in 2017. This is attributed to increasing prevalence of various types of cancer and rising demand for effective treatment therapies. According to the data published by WHO, in 2018, around 1 in 6 women and 1 in 5 men are estimated to be diagnosed with some form of cancer during their lifetime.
Cancer chemotherapy involves use of drugs that target different mechanisms involved in cell death pathway leading to increased survival rates among patients suffering from advanced stages of cancers such as lung, colorectal, pancreatic & liver cancers. As a result, this application segment is expected register lucrative growth over the forecast period owing to its high penetration rate across geographies coupled with increasing usage rates among oncology patients globally.
Regional Analysis:
North America dominated the global market in 2017. The presence of well-established healthcare infrastructure, favorable reimbursement policies, and increasing awareness about cancer treatments are some of the major factors responsible for its dominance. Moreover, rising prevalence of chronic diseases such as obesity and diabetes is also expected to boost demand for oncological drugs in this region.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to improving healthcare facilities and growing patient awareness regarding available treatment options in this region coupled with rising disposable income levels. In addition, government initiatives aimed at reducing drug prices by fostering competition are likely to attract significant investment from multinational pharmaceutical companies thereby driving growth during the forecast period. ‘‘‘‘’ ⓠ✠✠Cancer cachexia affects more than 1 million people annually in U.S.
Growth Factors:
- Increasing incidence of cancer
- Growing awareness about cancer cachexia and its treatment options
- Rising demand for effective and affordable therapies for cancer cachexia
- Proliferation of targeted therapies and personalized medicine for cancer treatment 5. Technological advancements in the field of oncology
Scope Of The Report
Report Attributes
Report Details
Report Title
Cancer Cachexia Market Research Report
By Type
Progestogens, Corticosteroids, Combination Therapies, Others
By Application
Hospital Stores, Retails Pharmacy Store, Online Pharmacy
By Companies
Aeterna Zentaris, Alder BioPharmaceuticals, Aphios, Eli Lilly, GTx, Helsinn, Merck, Novartis, Bristol-Myers Squibb, XBiotech
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
203
Number of Tables & Figures
143
Customization Available
Yes, the report can be customized as per your need.
Global Cancer Cachexia Market Report Segments:
The global Cancer Cachexia market is segmented on the basis of:
Types
Progestogens, Corticosteroids, Combination Therapies, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Stores, Retails Pharmacy Store, Online Pharmacy
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Aeterna Zentaris
- Alder BioPharmaceuticals
- Aphios
- Eli Lilly
- GTx
- Helsinn
- Merck
- Novartis
- Bristol-Myers Squibb
- XBiotech
Highlights of The Cancer Cachexia Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Progestogens
- Corticosteroids
- Combination Therapies
- Others
- By Application:
- Hospital Stores
- Retails Pharmacy Store
- Online Pharmacy
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Cancer Cachexia Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Cachexia is a condition that occurs when the body loses too much weight and muscle mass. This can lead to anemia, weakness, and fatigue. Cachexia also affects the skin, hair, and nails.
Some of the major players in the cancer cachexia market are Aeterna Zentaris, Alder BioPharmaceuticals, Aphios, Eli Lilly, GTx, Helsinn, Merck, Novartis, Bristol-Myers Squibb, XBiotech.
The cancer cachexia market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Cancer Cachexia Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Cancer Cachexia Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Cancer Cachexia Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Cancer Cachexia Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Cancer Cachexia Market Size & Forecast, 2020-2028
4.5.1 Cancer Cachexia Market Size and Y-o-Y Growth
4.5.2 Cancer Cachexia Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Progestogens
5.2.2 Corticosteroids
5.2.3 Combination Therapies
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital Stores
6.2.2 Retails Pharmacy Store
6.2.3 Online Pharmacy
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Cancer Cachexia Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Cancer Cachexia Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Progestogens
9.6.2 Corticosteroids
9.6.3 Combination Therapies
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital Stores
9.10.2 Retails Pharmacy Store
9.10.3 Online Pharmacy
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Progestogens
10.6.2 Corticosteroids
10.6.3 Combination Therapies
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital Stores
10.10.2 Retails Pharmacy Store
10.10.3 Online Pharmacy
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Progestogens
11.6.2 Corticosteroids
11.6.3 Combination Therapies
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital Stores
11.10.2 Retails Pharmacy Store
11.10.3 Online Pharmacy
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Progestogens
12.6.2 Corticosteroids
12.6.3 Combination Therapies
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital Stores
12.10.2 Retails Pharmacy Store
12.10.3 Online Pharmacy
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Progestogens
13.6.2 Corticosteroids
13.6.3 Combination Therapies
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital Stores
13.10.2 Retails Pharmacy Store
13.10.3 Online Pharmacy
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Cancer Cachexia Market: Competitive Dashboard
14.2 Global Cancer Cachexia Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Aeterna Zentaris
14.3.2 Alder BioPharmaceuticals
14.3.3 Aphios
14.3.4 Eli Lilly
14.3.5 GTx
14.3.6 Helsinn
14.3.7 Merck
14.3.8 Novartis
14.3.9 Bristol-Myers Squibb
14.3.10 XBiotech
